Ameriprise Financial Inc Ascendis Pharma A/S Transaction History
Ameriprise Financial Inc
- $375 Billion
- Q4 2024
A detailed history of Ameriprise Financial Inc transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Ameriprise Financial Inc holds 702,561 shares of ASND stock, worth $107 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
702,561
Previous 669,717
4.9%
Holding current value
$107 Million
Previous $100 Million
3.29%
% of portfolio
0.03%
Previous 0.03%
Shares
24 transactions
Others Institutions Holding ASND
# of Institutions
236Shares Held
60.2MCall Options Held
80.3KPut Options Held
216K-
Ra Capital Management, L.P. Boston, MA10.1MShares$1.54 Billion22.55% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.53MShares$842 Million3.52% of portfolio
-
Avoro Capital Advisors LLC New York, NY5.1MShares$777 Million10.24% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI4.45MShares$678 Million0.98% of portfolio
-
Janus Henderson Group PLC London, X04.38MShares$667 Million0.32% of portfolio
About Ascendis Pharma A/S
- Ticker ASND
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,810,200
- Market Cap $8.5B
- Description
- Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...